Anti-SLC22A6 antibody - C-terminal
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Polyclonal SLC22A6 antibody. C-terminal. Suitable for IHC-P and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human SLC22A6 aa 550 to C-terminus.
View Alternative Names
OAT1, PAHT, SLC22A6, Solute carrier family 22 member 6, Organic anion transporter 1, PAH transporter, Renal organic anion transporter 1, hOAT1, hPAHT, hROAT1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SLC22A6 antibody - C-terminal (AB183086)
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue labeling SLC22A6 using ab183086 at a 1/50 dilution, imageon the right is treated with the synthetic peptide.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SLC22A6 plays a role in the renal secretion of endogenous substances and drugs. It is part of the organic anion transporter family and participates in the elimination of molecules such as prostaglandins urate and multiple pharmaceutical agents. By functioning in concert with other transporter proteins SLC22A6 influences the pharmacokinetics of drugs and the clearance of metabolic waste products. Its activity ensures the proper balance of organic anions contributing to homeostasis.
Pathways
SLC22A6 integrates into the metabolic and excretory pathways in the kidney. It is part of the metabolic detoxification process capturing drugs and metabolites for renal excretion. The transporter works in a network that includes proteins such as SLC22A8 and urate-anion exchanger (URAT1) ensuring efficient substance clearance. In drug metabolism SLC22A6 interaction determines drug disposition with implications for drug efficacy and toxicity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Life medicine 2:lnad047 PubMed39872058
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 21:998-1009 PubMed26236991
2015
Applications
IHC-P, WB
Species
Mouse, Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com